FoxO3a involved in neutrophil and T cell survival is overexpressed in rheumatoid blood and synovial tissue

Annals of the Rheumatic Diseases

Volumn 69, Issue 4, 2010, Pages 755-760

  Turrel Davin, Fanny ^a,b   Tournadre, Anne ^a,b,c   Pachot, Alexandre ^a,b   Arnaud, Béatrice ^a,b   Cazalis, Marie Angélique ^a,b   Mougin, Bruno ^a,b   Miossec, Pierre ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b University of Lyon   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR FKHRL1;

ADULT; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; MICROARRAY ANALYSIS; NEUTROPHIL; OSTEOARTHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE;

ADULT; ARTHRITIS, RHEUMATOID; CELL SURVIVAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUTROPHILS; OSTEOARTHRITIS; PHOSPHORYLATION; RNA, MESSENGER; SYNOVIAL MEMBRANE; T-LYMPHOCYTES;

EID: 77950335818     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.109991     Document Type: Article

References (36)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-361
2. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003;100:2610-2615
3. Batliwalla FM, Baechler EC, Xiao X, et al. Peripheral blood gene expression profi ling in rheumatoid arthritis. Genes Immun 2005;6:388-397
4. Bomprezzi R, Ringnér M, Kim S, et al. Gene expression profi le in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 2003;12:2191-2199
5. Riou C, Yassine-Diab B, Van grevenynghe J, et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med 2007;204:79-91.
6. Tran H, Brunet A, Griffith EC, et al. The many forks in FOXO's road. Sci STKE 2003;172:RE5.
7. Ludikhuize J, de Launay D, Groot D, et al. Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. Arthritis Rheum 2007;56:2180-2191
8. Lin L, Hron JD, Peng SL. Regulation of NF-kappaB, Th activation, and autoinfl ammation by the forkhead transcription factor Foxo3a. Immunity 2004;21:203-213
9. Jonsson H, Allen P, Peng SL. Infl ammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat Med 2005;11:666-671
10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classifi cation of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
11. Gonzalez-Barderas M, Gallego-Delgado J, Mas S, et al. Isolation of circulating human monocytes with high purity for proteomic analysis. Proteomics 2004;4:432-437
12. Pachot A, Blond JL, Mougin B, et al. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantifi cation in peripheral whole blood. J Biotechnol 2004;114:121-124
13. Toh ML, Marotte H, Blond JL, et al. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infl iximab treatment. Arthritis Rheum 2006;54:2109-2118
14. Charpin C, Devictor B, Bonnier P, et al. Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors. J Pathol 1993;170:463-470
15. Liu H, Pope RM. The role of apoptosis in rheumatoid arthritis. Curr Opin Pharmacol 2003;3:317-322
16. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004;117:421-426
17. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002;29:23-39.
18. Mowat AG, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Clin Invest 1971;50:2541-2549
19. Goddard DH, Kirk AP, Kirwan JR, et al. Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis. Ann Rheum Dis 1984;43:151-156
20. Elmgren J, Hansen TH. Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent. Ann Rheum Dis 1985;44:514-518
21. Turner RA, Johnson JA, Turner SR. Neutrophil responsiveness to chemoattractant tripeptide in rheumatoid arthritis. Proc Soc Exp Biol Med 1987;186:125-133
22. Leirisalo-Repo M, Paimela L, Koskimies S, et al. Functions of polymorphonuclear leukocytes in early rheumatoid arthritis. Inflammation 1993;17:427-442
23. Howe GB, Fordham JN, Brown KA, et al. Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome. Ann Rheum Dis 1981;40:370-375
24. King SL, Parker J, Cooper R, et al. Polymorphonuclear leucocyte function in rheumatoid arthritis. Br J Rheumatol 1986;25:26-33.
25. Brown KA. The polymorphonuclear cell in rheumatoid arthritis. Br J Rheumatol 1988;27:150-155
26. Espersen GT, Ernst E, Vestergaard M, et al. Changes in PMN leukocyte migration activity and complement C3d levels in RA patients with high disease activity during steroid treatment. Scand J Rheumatol 1989;18:51-56
27. Wandal JH. Leucocyte function in patients with rheumatoid arthritis : quantitative in vivo leucocyte mobilization and in vitro functions of blood and exudate leucocytes. Ann Rheum Dis 1985;44:694-700.
28. Weinmann P, Moura RA, Caetano-Lopes JR, et al. Delayed neutrophil apoptosis in very early rheumatoid arthritis patients is abrogated by methotrexate therapy. Clin Exp Rheumatol 2007;25:885-887
29. Kasama T, Kobayashi K, Yajima N, et al. Expression of vascular endothelial growth factor by synovial fl uid neutrophils in rheumatoid arthritis (RA). Clin Exp Immunol 2000;121:533-538
30. Scapini P, Lapinet-Vera JA, Gasperini S, et al. The neutrophil as a cellular source of chemokines. Immunol Rev 2000;177:195-203.
31. Dijkers PF, Medema RH, Pals C, et al. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 2000;20:9138-9148
32. Medema RH, Kops GJ, Bos JL, et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000;404:782-787
33. Schmidt M, Fernandez de Mattos S, van der Horst A, et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 2002;22:7842-7852
34. Dijkers PF, Medema RH, Lammers JW, et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 2000;10:1201-1204
35. Tang TT, Dowbenko D, Jackson A, et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem 2002;277:14255-14265
36. Kops GJ, Dansen TB, Polderman PE, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002;419:316-321